Home Uncategorized

Uncategorized

STALIF M FLX 3D-Printed ALIF Device Listed by SPINEMarketGroup as the Top ALIF 3D-printed Cage

STALIF M FLX platform represents the latest material advancement offered by Centinel Spine.

Post-Pandemic, Many U.S. Frontline Workers Plan To Keep Up Habits That Help Protect From Infection

With the recent authorization and phased distribution of two COVID-19 vaccines, there are early indications that an end to our current global health crisis is in our sights.

Qosina Offers Vast Selection of Critical Care Components for Respiratory Medical Device Design

Qosina offers countless off-the-shelf solutions for oxygen and respiratory medical device projects, stocking a range of non-sterile respiratory care components in a variety of materials, sizes, colors, and configurations.

IAI Announces Medical Assist ELECYLINDER Series

The main features are easy operation, AVD (acceleration / speed / deceleration) that can be adjusted individually, and high performance. Due to its stable quality, it is ideal for the manufacturing industry of medical products where product accuracy is required.

Medovate Forms Partnership with Konica Minolta Healthcare Americas to Promote Best Practice in Regional Anesthesia

The partnership will highlight the provision of Ultrasound-Guided Regional Anesthesia and how the revolutionary SAFIRA™ can be used in conjunction with Konica Minolta Healthcare Americas’ range of pioneering ultrasound solutions.

Richard Francis Intended to be Appointed Purespring Therapeutics CEO Following Completion of Its Series A Financing of £45.0 Mil, from 1 February 2021

Richard is a leading pharmaceutical executive with over 25 years’ experience in building sustainable, world-class life science companies. He most recently held the role of Chief Executive Officer of Sandoz, a division of Novartis. Sandoz is a global leader in generic pharmaceuticals and biosimilars.

Atriomx Health Announces $10 Million Series A Financing-Funds to Be Used for Development and Clinical Study

"This financing will allow Atriomx to pursue the tremendous opportunity to transform the diagnosis and treatment of atrial fibrillation stemming from the application of novel AF detection and characterization capabilities to data that can be collected non-invasively," said Duke Rohlen, CEO of Ajax Health and Zeus Health.